Invention Grant
- Patent Title: Diblock copolymers and polynucleotide complexes thereof for delivery into cells
-
Application No.: US15264392Application Date: 2016-09-13
-
Publication No.: US09862792B2Publication Date: 2018-01-09
- Inventor: Patrick S. Stayton , Allan S. Hoffman , Anthony J. Convertine , Danielle Benoit , Craig L. Duvall , Paul H. Johnson , Anna S. Gall
- Applicant: University of Washington , PhaseRx, Inc.
- Applicant Address: US WA Seattle US WA Seattle
- Assignee: University of Washington,PhaseRx, Inc.
- Current Assignee: University of Washington,PhaseRx, Inc.
- Current Assignee Address: US WA Seattle US WA Seattle
- Agency: Christiansen O'Connor Johnson Kindness PLLC
- Main IPC: A61K31/713
- IPC: A61K31/713 ; A61K47/32 ; C08F293/00 ; C12N15/113 ; A61K47/48

Abstract:
Described herein are copolymers, and methods of making and utilizing such copolymers. Such copolymers have at least two blocks: a first block that has at least one unit that is hydrophilic at physiologic pH, and a second block that has hydrophobic groups. This second block further has at least one unit with a group that is anionic at about physiologic pH. The described copolymers are disruptive of a cellular membrane, including an extracellular membrane, an intracellular membrane, a vesicle, an organelle, an endosome, a liposome, or a red blood cell. Preferably, in certain instances, the copolymer disrupts the membrane and enters the intracellular environment. In specific examples, the copolymer is endosomolytic.
Public/Granted literature
- US20170096517A1 DIBLOCK COPOLYMERS AND POLYNUCLEOTIDE COMPLEXES THEREOF FOR DELIVERY INTO CELLS Public/Granted day:2017-04-06
Information query